
THER
Healthcare · Biotechnology · $615,149 market cap
$0.00010.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 20, 2024 | After the close | — | -0.00 | — |
| Feb 21, 2023 | Time not confirmed | — | -0.01 | — |
| Dec 29, 2022 | Time not confirmed | — | -0.00 | — |
| Aug 15, 2022 | Time not confirmed | — | -0.00 | — |
| May 23, 2022 | Time not confirmed | — | -0.00 | — |
| Feb 18, 2022 | Time not confirmed | — | -0.00 | — |
| Sep 27, 2021 | Time not confirmed | — | -0.06 | — |
| Jun 11, 2021 | Time not confirmed | — | -0.57 | — |
| May 15, 2020 | Time not confirmed | — | -5.73 | — |
| Mar 25, 2020 | Time not confirmed | — | -4.35 | — |
| Nov 19, 2019 | Time not confirmed | — | -2.31 | — |
| Aug 15, 2019 | Time not confirmed | — | -0.01 | — |
| Apr 1, 2019 | Time not confirmed | — | 1.30 | — |
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision oncology data…
| Time not confirmed |
| — |
| -1.97 |
| — |
| Aug 14, 2018 | Time not confirmed | — | -0.02 | — |
| May 31, 2018 | After the close | — | 13.97 | — |